Mohan Pankaj
Insider CIK 1664386 · SONN Chairman, President and CEO, Director, 10% owner · ONS President & CEO, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SONN Sonnet BioTherapeutics Hol | A Award | 2023-12-11 | 2024-12-05 | 7,554 | — | $0 | 14,987 | SEC↗ |
| SONN Sonnet BioTherapeutics Hol | P Buy deriv | 2023-10-27 | 2023-10-27 | 68,750 | — | $0 | 68,750 | SEC↗ |
| SONN Sonnet BioTherapeutics Hol | P Buy | 2023-10-27 | 2023-10-27 | 34,375 | — | $0 | 59,526 | SEC↗ |
| SONN Sonnet BioTherapeutics Hol | P Buy | 2023-05-15 | 2023-05-15 | 371,600 | $0.22 | $81.8K | 553,331 | SEC↗ |
| SONN Sonnet BioTherapeutics Hol | P Buy | 2023-03-15 | 2023-03-16 | 60,000 | $0.59 | $35.4K | 181,731 | SEC↗ |
| SONN Sonnet BioTherapeutics Hol | D To issuer | 2023-01-07 | 2023-02-17 | 73,561 | — | $0 | 48,170 | SEC↗ |
| SONN Sonnet BioTherapeutics Hol | A Award | 2023-01-07 | 2023-02-17 | 73,561 | — | $0 | 121,731 | SEC↗ |
| SONN Sonnet BioTherapeutics Hol | A Award | 2022-12-14 | 2022-12-22 | 74,205 | — | $0 | 748,606 | SEC↗ |
| SONN Sonnet BioTherapeutics Hol | A Award | 2021-12-15 | 2022-04-08 | 320,135 | — | $0 | 674,401 | SEC↗ |
| SONN Sonnet BioTherapeutics Hol | P Buy | 2021-06-09 | 2021-06-09 | 4,000 | $1.55 | $6.2K | 326,266 | SEC↗ |
| SONN Sonnet BioTherapeutics Hol | P Buy | 2021-06-09 | 2021-06-09 | 28,000 | $1.55 | $43.4K | 354,266 | SEC↗ |
| SONN Sonnet BioTherapeutics Hol | A Award | 2020-07-02 | 2020-07-02 | 319,866 | — | $0 | 322,266 | SEC↗ |
| SONN Sonnet BioTherapeutics Hol | P Buy | 2020-06-10 | 2020-06-12 | 2,400 | $4.09 | $9.8K | 2,400 | SEC↗ |
| SONN Sonnet BioTherapeutics Hol | A Award deriv | 2020-04-01 | 2020-04-03 | 4,263 | — | $0 | 4,263 | SEC↗ |
| SONN Sonnet BioTherapeutics Hol | A Award | 2020-04-01 | 2020-04-03 | 1,591,116 | — | $0 | 1,591,116 | SEC↗ |
| SONN Sonnet BioTherapeutics Hol | A Award | 2020-04-01 | 2020-04-03 | 7,992 | — | $0 | 7,992 | SEC↗ |
| SONN Sonnet BioTherapeutics Hol | A Award | 2020-04-01 | 2020-06-05 | 930,705 | — | $0 | 930,705 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2019-01-15 | 2019-01-17 | 8,000 | $0.68 | $5.4K | 7,064,553 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award deriv | 2018-11-09 | 2018-11-13 | 114,157 | $0.61 | $69.6K | 114,157 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award deriv | 2018-09-21 | 2018-09-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ONS Oncobiologics, Inc. | S Sale | 2018-01-04 | 2018-01-05 | 62,569 | $1.16 | $72.6K | 7,056,553 | SEC↗ |
| ONS Oncobiologics, Inc. | S Sale | 2018-01-03 | 2018-01-05 | 52,108 | $1.18 | $61.5K | 7,119,122 | SEC↗ |
| ONS Oncobiologics, Inc. | S Sale | 2017-12-19 | 2017-12-20 | 83,608 | $1.14 | $95.3K | 7,171,230 | SEC↗ |
| ONS Oncobiologics, Inc. | S Sale | 2017-12-18 | 2017-12-20 | 20,523 | $1.17 | $24.0K | 7,254,838 | SEC↗ |
| ONS Oncobiologics, Inc. | C Conversion deriv | 2016-05-18 | 2016-05-18 | 106 | — | $0 | 0 | SEC↗ |
| ONS Oncobiologics, Inc. | C Conversion | 2016-05-11 | 2016-05-18 | 17,666 | — | $0 | 39,405 | SEC↗ |